Fundraising Fox
/Companies
Sign in

Cerberus Therapeutics

Boston, US · Founded 2020 · Delaware corporation · 7 employees on LinkedIn · 2 known investors

Find your way into Cerberus Therapeutics

Sign up to see every warm intro you have to Cerberus Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cerberus Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Cerberus Therapeutics is a biotechnology company developing therapeutics based on nanobody technology, a tolerance induction platform, and a KappaLink platform. Its work focuses on immune tolerance and antibody-based drug development.

BiotechDeep TechHealthtech

Founders & leadership

Cerberus Therapeutics was founded in 2020 by Novalia Pishesha, Hidde Ploegh, Novalia Pishesha, PhD, Hidde L. Ploegh, PhD, and Harvey F. Lodish, PhD.

NPNovalia Pishesha
Novalia PisheshaCo-Founder
HPHidde Ploegh
Hidde PloeghFounder
NP
Novalia Pishesha, PhDCo-founder, BoD, SAB
HLHidde L. Ploegh, PhD
Hidde L. Ploegh, PhDCo-Founder, SAB
HFHarvey F. Lodish, PhD
Harvey F. Lodish, PhDCo-Founder, BoD
XS
Xiaohong SangNamed on SEC filing
XJ
Xiaowei JinNamed on SEC filing
HL
Harvey LodishFounder

Investors · 2

Sherpa Healthcare PartnersreportedGrand Cayman

How we know: cerberustx.com · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$4M disclosed across 1 of 2 rounds · 2021–2023

▶$4MraisedJan 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Xiaohong SangExecutive Officer
  • Xiaowei JinDirector
  • Harvey LodishDirector
  • Novalia PisheshaExecutive Officer, Director
Offering amount
$5M
Amount sold
$4M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Cerberus VenturesCerberus is a multi-platform investment firm that manages capital across diverse asset classes including direct lending, private equity, real estate, credit, and venture capital. The company serves institutional investors and business partners globally through its integrated investment platforms.

Companies working in the same space as Cerberus Therapeutics.

In the news

Cerberus Therapeutics Secures $5 Million Strategic Investment - Cerberus Therapeuticscerberustx.com · Dec 2023Cerberus Therapeutics Secures $4mm in Seed Investment - Cerberus Therapeuticscerberustx.com · Dec 2021

Frequently asked questions

What does Cerberus Therapeutics do?
Cerberus Therapeutics is a biotechnology company developing therapeutics based on nanobody technology, a tolerance induction platform, and a KappaLink platform. Its work focuses on immune tolerance and antibody-based drug development.
Who founded Cerberus Therapeutics?
Cerberus Therapeutics was founded by Novalia Pishesha, Hidde Ploegh, Novalia Pishesha, PhD, Hidde L. Ploegh, PhD, Harvey F. Lodish, PhD in 2020.
Who are Cerberus Therapeutics's investors?
Cerberus Therapeutics's investors include Bill & Melinda Gates Foundation, Sherpa Healthcare Partners.
How much funding has Cerberus Therapeutics raised?
Cerberus Therapeutics has disclosed $4M raised across 1 of its 2 known rounds.
Where is Cerberus Therapeutics headquartered?
Cerberus Therapeutics is headquartered in Boston, US.